comparemela.com
Home
Live Updates
Significant Medical Community Interest - Breaking News
Pages:
Latest Breaking News On - Significant medical community interest - Page 1 : comparemela.com
Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance
/PRNewswire/ Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for.
United states
Aaron palash
Michael freitag
Daniel speciale
Joele frank
Peter richardson
Siggi olafsson
Prnewswire mallinckrodt
Derek belz
Wilkinson brimmer katcher
Exchange commission
Us drug enforcement administration
Significant medical community interest
Product development pipelines
Mallinckrodt pharmaceuticals
Company specialty brands
vimarsana © 2020. All Rights Reserved.